The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

We all want to eat foods that keep us strong, energized, and feeling our best, but we also all know that the typical American ...

Many cat owners overfeed their pets without realizing it, leading to obesity, health issues, and decreased energy levels. If ...

Dr Eric Bernicker, an oncologist, has shared the five habits he believes everyone should add to their lifestyles to live as ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply squeeze on Novo Nordisk’s diabetes and obesity counterpa | The FDA has ...

Because almost no existing diet programs focus specifically on reducing ultra-processed food intake, researchers from Drexel ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.

Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

NEWARK, CA / ACCESS Newswire / February 21, 2025 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended ...

Obesity affects over a third of Missouri's adults and children, with rural areas hit hardest. It's a complex issue linked to mental health and accessibility, not just personal choice.